Newtyn Management, LLC - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 65 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.

Quarter-by-quarter ownership
Newtyn Management, LLC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$23,102,647
+0.2%
1,873,6940.0%5.70%
+4.7%
Q2 2023$23,046,436
+0.1%
1,873,6940.0%5.44%
+20.3%
Q1 2023$23,027,699
+13.6%
1,873,694
+6.0%
4.52%
+8.2%
Q4 2022$20,265,795
+205.8%
1,768,394
+0.1%
4.18%
+187.4%
Q3 2022$6,627,000
-36.6%
1,767,094
+0.5%
1.46%
-26.6%
Q2 2022$10,460,000
-3.4%
1,758,005
+2.6%
1.98%
-23.6%
Q1 2022$10,830,000
+78.8%
1,713,612
+10.6%
2.59%
+61.3%
Q4 2021$6,056,000
-19.0%
1,548,8830.0%1.61%
-19.4%
Q3 2021$7,481,000
-24.2%
1,548,8830.0%2.00%
-27.0%
Q2 2021$9,866,000
+1.8%
1,548,8830.0%2.73%
+4.4%
Q1 2021$9,696,000
-9.1%
1,548,8830.0%2.62%
+6.5%
Q4 2020$10,672,000
+105.8%
1,548,883
+19.5%
2.46%
+95.5%
Q3 2020$5,186,000
+29.8%
1,296,436
+8.1%
1.26%
-14.0%
Q2 2020$3,995,000
+58.4%
1,199,606
+2.3%
1.46%
+68.4%
Q1 2020$2,522,000
-31.7%
1,173,1660.0%0.87%
+154.5%
Q4 2019$3,695,000
-29.9%
1,173,1660.0%0.34%
-31.2%
Q3 2019$5,268,000
-28.2%
1,173,166
-3.2%
0.50%
-47.6%
Q2 2019$7,333,000
-7.8%
1,212,144
+5.9%
0.95%
-37.0%
Q1 2019$7,955,000
+131.9%
1,144,583
+28.8%
1.50%
+124.1%
Q4 2018$3,430,000
-4.7%
888,620
+31.6%
0.67%
+8.9%
Q3 2018$3,598,000
+15.7%
675,000
+6.6%
0.62%
+5.8%
Q2 2018$3,109,000
+174.2%
633,297
+349.6%
0.58%
+188.1%
Q1 2018$1,134,000
-69.5%
140,857
-61.1%
0.20%
-64.4%
Q4 2017$3,714,000
-34.5%
362,335
-7.1%
0.57%
-38.0%
Q3 2017$5,671,000390,0000.92%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Western Standard LLC 1,894,013$23,353,18021.09%
Newtyn Management, LLC 1,873,694$23,102,6475.70%
Sio Capital Management, LLC 288,466$3,556,7861.10%
Madison Avenue Partners, LP 553,085$6,819,5380.97%
WITTENBERG INVESTMENT MANAGEMENT, INC. 209,739$2,5860.95%
Indaba Capital Management, L.P. 136,802$1,686,7690.50%
Sepio Capital, LP 306,680$3,781,3640.33%
Yakira Capital Management, Inc. 54,118$667,2750.18%
Centiva Capital, LP 187,803$2,315,6110.05%
FIFTH LANE CAPITAL, LP 10,929$134,4270.05%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders